Skip to content
Govbase
Govbase
Congress·In Committee·S. 1830

Sen. Johnson Introduces Right to Treat Act to Limit Federal Oversight of Doctors

Right to Treat Act

Legislative Progress

Senate
House
President
Law

Key Points

  • The bill would prevent federal agencies — including the FDA, NIH, and CDC — from regulating how doctors practice medicine. This is a major shift that would limit the federal government's ability to set standards for medical treatments.

    From policy text

    no Federal agency, including the Food and Drug Administration, the National Institutes of Health, and the Centers for Disease Control and Prevention, shall have the authority to regulate the practice of medicine
    View in full text
  • Doctors would be free to prescribe any FDA-approved drug for "off-label" uses — meaning for conditions or purposes the drug wasn't originally approved to treat — without federal interference. This also extends to drugs available through the Right to Try pathway.

    From policy text

    no Federal law, rule, regulation, or policy shall prohibit or restrict the prescription or disbursement for an unapproved use of any drug that is approved by the Food and Drug Administration, or that is available pursuant to section 561B of the Federal Food, Drug, and Cosmetic Act
    View in full text
  • The bill carves out major exceptions: federal rules restricting abortion, assisted suicide, euthanasia, gender transition treatments, and female genital mutilation would remain fully in place. These medical areas would not gain any new protections under the bill.

    From policy text

    Nothing in this Act shall be construed to affect any Federal law, rule, regulation, or policy that restricts abortion, assisted suicide, euthanasia, mercy killing, coercive family planning, female genital mutilation, or gender transition medical interventions.
    View in full text
  • The bill was introduced by Sen. Johnson and referred to the Senate HELP Committee. If enacted, it would represent a fundamental change in how federal health agencies interact with medical practice, reducing their oversight role significantly.
Healthcare

Impact Analysis

Personal Impact

Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)

Milestones

2 milestones3 actions
Mar 19, 2026Senate

Committee on Health, Education, Labor, and Pensions. Hearings held.

May 21, 2025Senate

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

May 21, 2025

Introduced in Senate

What Happens Next

Projected impacts based on AI analysis

Upon enactment

If enacted, federal agencies like the FDA and CDC would immediately lose authority to regulate medical practice

Doctors could prescribe any FDA-approved drug for any purpose without fear of federal enforcement. Patients could see faster access to off-label treatments, but also fewer safety guardrails.

Source Information

Document Type

Congressional Bill

Official Title

Right to Treat Act

Bill NumberS 1830
Congress119th Congress
ChamberSenate
Latest ActionCommittee on Health, Education, Labor, and Pensions. Hearings held.

Sponsor

Analysis generated by AI. Always verify with official sources.